Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate
Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate
Anebulo Pharmicals第二季度每股收益美元（0.11）未達到預期（0.10）
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 26.67 percent increase over losses of $(0.15) per share from the same period last year.
Anebulo Pharmicals（納斯達克股票代碼：ANEB）公佈的季度虧損爲每股0.11美元，比分析師普遍預期的0.10美元（0.10美元）低10％。這比去年同期每股虧損0.15美元（0.15美元）增長了26.67％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。